141
cryoglobulinemia:a pilot study. J Hepatol. 2005;42:632-8.
21
Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC. Pegylated interferon
alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic
vasculitis. Arthritis Rheum. 2005;52:911-5.
22 Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E et al. Treatment
of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with
ribavirin and interferon-alpha. J Rheumatol. 2000;27:2172-8.
23 Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis
C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-
analysis. Gastroenterology 2003;125:1723-32.
24 Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis
C virus infection in patients with lymphoproliferative disorders. Blood. 1996;87:4296-
301.
25 Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, et al. Prevalence of bcl-
2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia
with or without B-cell lymphomas.Ann Intern Med. 2002;137:571-80.
26 Vallisa D, Berte R, Rocca A, Civardi G, Giangregorio F, Ferrari B, et al. Association
between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection
on histologic subtype and clinical course. Am J Med. 1999;106:556-60.
27 Kami M, Hamaki T, Murashige N, Kishi Y, Kusumi E, Yuji K, Miyakoshi S, et al. Safety
of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection.
Hematol J. 2003;4:159-62.
28 Nakajima H, Takagi H, Yamazaki Y, Toyoda M, Takezawa J, Nagamine T, et al.
Immune thrombocytopenic purpura in patients with hepatitis virus infection.
Hepatogastroenterology. 2005;52:1197-2000.
29 Ramos-Casals M, Garcia-Carrasco M, Lopez-Medrano F, Trejo O, Forns X, López-
Guillermo A, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C
virus infection:clinical description of 35 cases. Medicine (Baltimore). 2003;82:87-96.
30 Lambrech tRW,Bonkovsky HL.Hemochromatosis and porphyria. Semin Gastrointest
Dis. 2002;13:109-19
31
Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et
al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
Hepatology 1998;27:1661-9.
32 Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F,et al. Oral lichen planus
pathogenesis: A role for the HCV-specific cellular immune response. Hepatology.
2002;36:1446-52
33 Karlsberg PL, Lee WM, Casey DL, Cockerell CJ, Cruz PD JR. Cutaneous vasculitis
and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced
mixed cryoglobulinemia. Arch Dermatol. 1995131:1119-23.
34 Bandi L. Renal manifestations of hepatitis C virus infection. Extrahepatic
complications often are silent and thus overlooked. Postgrad Med. 2003;113:73-6,
86.
35 Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al.
Membranoproliferative glomerulonephritis associated with hepatitis C virus
infection.N Engl J Med. 1993: 18;328:465-70.
36 Sabry AA, Sobh MA, Sheaashaa HA, Kudesia G, Wild G, Fox S, et al. Effect of
combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
Nephrol Dial Transplant. 2002;17:1924-30
37 Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M, et al. Hepatitis
Hepatit C Enfeksiyonunun Klinik Bulguları
